Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

NDA for abarelix depot officially filed by FDA; drug assigned priority review status

Jan. 26, 2001

Introgen awarded SBIR grant to study INGN-241 as lung cancer treatment

Jan. 25, 2001

Tamoxifen for breast cancer prevention does not alter cardiovascular risk

Jan. 25, 2001

Potential of telomerase inhibitors for chemoprevention emerges from recent research

Jan. 25, 2001

Scotia's Foscan receives negative opinion from EMEA

Jan. 24, 2001

Medarex and B. Twelve to develop human antibody therapeutics for cancer

Jan. 24, 2001

Novel oral cancer treatments to be codeveloped by Celltech and Johnson & Johnson

Jan. 23, 2001

Oral formulation of Fludara now available in U.K.

Jan. 23, 2001

Second-generation retroviral BRCA1 vector for ovarian cancer has improved preclinical profile

Jan. 23, 2001

British Biotech provides update on clinical development of marimastat

Jan. 23, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...